News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
217–252
Matches
526
Sources here
18
Companies here
9
Search results Stored financial headlines

Active search

526 matching headlines

Ticker or company: NEOMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Earnings call transcript: Neogen tops Q4 2026 estimates as shares jump 10%

Neogen Corporation reported stronger-than-expected fiscal fourth-quarter results for 2026, surpassing Wall Street estimates for both earnings and revenue, which led to a 10.43% jump in premarket shares. The company highlighted improved core growth across its food safety and animal safety segments, the highest food …

NEOG main company
Sharemaestro market context Trend signal started 52 weeks +106.6% NEOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neogen Q4 FY26 slides: food safety growth hits 3-year high

Neogen Corporation reported its strongest quarterly performance since its 2023 3M food safety acquisition, with core revenue growing 4.3% and food safety sales increasing by 5.8%, a three-year high. The company outlined a strategic shift towards sustainable growth through enhanced commercial operations, a 50% …

NEOG main company
Sharemaestro market context Trend signal started 52 weeks +106.6% NEOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street's Insights Into Key Metrics Ahead of Oneok (OKE) Q2 Earnings

The upcoming report from Oneok Inc. (OKE) is expected to reveal quarterly earnings of $1.39 per share, indicating an increase of 3.7% compared to the year-ago period. Analysts forecast revenues of $10.8 billion, representing an increase of 37% year over year. The consensus EPS …

OKE main company ONK main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neogen Food Safety Core Growth Hits 5.8%, Highest Since FY23

Neogen Corporation reported Q4 FY26 revenue of $225.3 million, with Food Safety core growth at 5.8%, the highest since FY23. The company also provided FY27 guidance, projecting revenues between $880 million and $885 million, and adjusted EBITDA of $180 million to $182 million. Neogen …

NEOG main company
Sharemaestro market context Trend signal started 52 weeks +106.6% NEOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SummitTX Capital L.P. Invests $1.50 Million in ONEOK, Inc. $OKE

SummitTX Capital L.P. has initiated a new position in ONEOK, Inc. (NYSE:OKE) by purchasing 16,607 shares valued at approximately $1.50 million in the first quarter. This investment is part of broader institutional activity in ONEOK stock, with several other firms also adjusting their holdings. …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoVolta Inc (NEOV) Institutional Confidence

This article provides details on the institutional confidence in NeoVolta Inc (NEOV), listing key shareholders and their holdings. As of July 29, 2026, the institutional confidence score remained at 3.00. Major institutional investors include Legacy Wealth Management, LLC, Infinite Grid Capital, and Davidson Kempner …

NEOV main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% NEOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates

Neogen (NEOG) reported Q4 earnings of $0.09 per share, significantly exceeding the Zacks Consensus Estimate of $0.05 per share, and also surpassed revenue estimates with $225.3 million. The company has consistently beaten revenue estimates over the last four quarters and has outperformed the S&P …

NEOG main company
Sharemaestro market context Trend signal started 52 weeks +106.6% NEOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neogen: Fiscal Q4 Earnings Snapshot

Neogen Corp. reported a fiscal fourth-quarter loss of $11.3 million, or 5 cents per share, which beat Wall Street expectations after adjustments. The medical testing kit maker posted revenue of $225.3 million for the quarter, also exceeding forecasts. For the full year, Neogen reported …

NEOG main company
Sharemaestro market context Trend signal started 52 weeks +106.6% NEOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NEOV Initiates Coverage On by Northland Capital Markets -- Ratin

Northland Capital Markets has initiated coverage on NeoVolta (NEOV) with an 'Outperform' rating and a $15.00 price target. GuruFocus indicates NEOV is significantly undervalued at $2.00, compared to its GF Value™ of $12.46, despite current unprofitability. While no gurus hold shares, insiders have purchased …

NEOV main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% NEOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inneova Holdings Ord Shs (INEO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Inneova Holdings Ord Shs (INEO), detailing its current support, resistance, and various technical indicators and moving averages. It offers insights into the stock's performance based on technical signals like MACD, RSI, and moving averages, presenting a neutral …

INEO main company
Sharemaestro market context Trend signal active 37 weeks -8.1% · Next-week setup negative 40.3% INEO stored weekly price path from 5 Dec 2025 to 14 Aug 2026

ONEOK Inc (OKE) - Tradingkey Stock Score & Comprehensive Stock Analysis

ONEOK Inc (OKE) has a relatively stable fundamental and high growth potential, with its valuation considered fairly valued. The company exhibits high institutional ownership and analysts have largely rated it as "Buy" with a target price of $95.68. The stock price is currently trading …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inneova Holdings Ord Shs (INEO) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Inneova Holdings Ord Shs (INEO), focusing on future EPS and revenue growth estimates. It includes current stock price information, market capitalization, and navigation to various analysis tools such as the TradingKey Stock Score, Price Momentum, Institutional Confidence, …

INEO main company
Sharemaestro market context Trend signal active 37 weeks -8.1% · Next-week setup negative 40.3% INEO stored weekly price path from 5 Dec 2025 to 14 Aug 2026

NeoGenomics, Inc. Stock 12‑Month Price Target Raised to $19.72, Implies 47% Upside

Analyst estimates have led to an increased average 12-month price target for NeoGenomics, Inc. (NEO) stock, rising from $16.78 to $19.72, with a range of $16 to $35 per share. This updated target suggests a potential upside of approximately 47% from its closing price …

NEO main company NEO main company
Sharemaestro market context Price below Trend Line 52 weeks -11.8% · Next-week setup negative 1.3% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ONEOK cut at Morgan Stanley on growth concerns, preferring Targa Resources (OKE:NYSE)

Morgan Stanley downgraded ONEOK (OKE) to Equal Weight from Overweight, lowering its price target due to concerns about the lack of investor conviction in the company's multiyear EBITDA growth. Despite seeing value in ONEOK, the firm is now preferring Targa Resources (TRGP). This indicates …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoGenomics (NEO) Stock Rallies As Profit Returns And Margins Improve

NeoGenomics (NEO) stock rallied by 14% after reporting a swing from a Q1 loss to a modest Q2 profit, driven by improved margins and increased average price per test. While clinical revenue and NGS growth are strong, concerns remain regarding the decline in pharma …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neonode Inc (NEON) Financial Health: Profitability & Balance Sheet Analysis

Neonode Inc (NEON) has a current financial score of 6.65, positioning it 41st out of 60 in the Electronic Equipment & Parts industry. Despite its robust financial status and low operating efficiency, the company reported a recent quarterly revenue of $614.00K, marking a 19.69% …

NEON main company
Sharemaestro market context Price below Trend Line 52 weeks -96.3% · Next-week setup negative 40.8% NEON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ONEOK, Inc. Stock 12‑Month Price Target Cut to $95.8, Implies 8% Upside

ONEOK, Inc.'s average 12-month price target has been lowered from $96.3 to $95.8 by 20 analysts, with individual forecasts ranging from $88 to $108 per share. This new target suggests an 8% potential upside from the July 28 closing price. Despite the slight reduction …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoVolta (NASDAQ:NEOV) Now Covered by Northland Securities

Northland Securities has initiated coverage on NeoVolta (NASDAQ:NEOV) with an "outperform" rating. Despite this new optimistic coverage, analyst sentiment for the company remains mixed, resulting in an average "Hold" rating and a $9.50 target price. The article highlights recent financial performance, insider buying by …

NEOV main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% NEOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ONEOK Inc Lobbyists, 2023

This OpenSecrets article details ONEOK Inc.'s lobbying activities and lobbyists for 2023. It highlights that ONEOK Inc. spent $330,000 on federal lobbying in 2026 (though the article focuses on 2023 specific lobbyist details) and lists 12 named lobbyists for 2023, with 6 having prior …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northland initiates NeoVolta stock with Outperform on utility shift By Investing.com

Northland initiated coverage of NeoVolta Inc. (NASDAQ: NEOV) with an Outperform rating and a $15.00 price target, noting the company's strategic shift from residential to utility Battery Energy Storage System (BESS) provision. This transition is being driven by a majority-owned joint venture with LONGi …

NEOV main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% NEOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target

Northland Securities has initiated coverage on NeoVolta Inc. (NEOV) with an Outperform rating and set a price target of $15.00. This report from Northland Securities provides a positive outlook for the energy technology company specializing in scalable storage solutions. NeoVolta Inc. develops and sells …

NEOV main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% NEOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

19,681 Shares in ONEOK, Inc. $OKE Bought by Talon Private Wealth LLC

Talon Private Wealth LLC acquired 19,681 shares of ONEOK, Inc. (NYSE:OKE) valued at approximately $1.78 million in the first quarter, contributing to institutional investors' 69.13% ownership of the company. Analyst sentiment for ONEOK is mixed, with a consensus "Hold" rating and an average price …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Needham raises Neogenomics stock price target on strong Q2 results

Needham has increased its price target for Neogenomics Inc. (NASDAQ:NEO) to $19.00 from $15.00, maintaining a Buy rating, following strong second-quarter 2026 results. The company surpassed revenue and EBITDA consensus estimates, leading management to raise full-year guidance and indicating a potential return to profitability …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Morgan Stanley downgrades ONEOK stock rating on growth concerns

Morgan Stanley downgraded ONEOK Inc. (NYSE:OKE) from Overweight to Equalweight and lowered its price target to $103 from $113, citing concerns about investor conviction in multiyear EBITDA growth and the company's less proportionate exposure to Permian growth. Despite forecasts suggesting ONEOK can achieve management's …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neogenomics stock hits 52-week high at 15.61 USD

NeoGenomics Inc. (NEO) stock reached a 52-week high of $15.61 USD, representing a 162.75% increase over the past year. Despite trading above its Fair Value, analysts are optimistic about the company turning profitable this year. This surge follows strong second-quarter 2026 earnings, where NeoGenomics …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Morgan Stanley Downgrades ONEOK to Equalweight From Overweight, Adjusts PT to $103 From $113

Morgan Stanley has downgraded ONEOK (OKE) from Overweight to Equalweight and revised its price target down to $103 from $113. This change reflects a more neutral outlook on the natural gas distributor's stock. The article also lists various other analyst adjustments for ONEOK throughout …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoGenomics Reports Second Quarter 2026 Results

NeoGenomics, Inc. announced its second-quarter 2026 results, showing an 11% year-over-year increase in total revenue to $202 million, with robust clinical services revenue growth of 14% driven by a 26% increase in NGS revenue. The company reported a GAAP net income of $2 million …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

California State Teachers Retirement System Has $153.97 Million Stock Position in ONEOK, Inc. $OKE

The California State Teachers Retirement System (CalSTRS) has reduced its holdings in ONEOK, Inc. by 1.8% in the first quarter, selling 31,910 shares but still retaining 1.70 million shares valued at $153.97 million. Institutional investors collectively own 69.13% of ONEOK, which maintains a "Hold" …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gamco Investors INC. ET AL Boosts Stock Holdings in NeoGenomics, Inc. $NEO

Gamco Investors INC. ET AL significantly increased its stake in NeoGenomics, Inc. by 525% in the first quarter, now holding 100,000 shares valued at $742,000. This move comes as NeoGenomics reported better-than-expected Q2 earnings and raised its fiscal 2026 revenue guidance, despite ongoing concerns …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arete Wealth Advisors LLC Purchases 34,665 Shares of ONEOK, Inc. $OKE

Arete Wealth Advisors LLC significantly increased its stake in ONEOK, Inc. (NYSE:OKE) during the first quarter, purchasing an additional 34,665 shares to bring their total holding to 54,666 shares valued at approximately $4.94 million. The company reported first-quarter earnings per share of $1.23, missing …

OKE main company
Sharemaestro market context Trend signal active 52 weeks +32.3% OKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context